Tenaya Therapeutics, Inc.
TNYAAs of the close on Sep 25, 2026
Price
$0.61
Market cap
$137M
P/E (diluted TTM)
—
Not meaningful: the last four quarters were a loss
EPS (TTM)
−$0.50
Four quarters to Jun 30, 2026
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Tenaya Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 29, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| EverSource Wealth Advisors, LLC | 2026-03-31 | 1,099 | $761 | SEC filing |
| CITADEL ADVISORS LLC | 2026-03-31 | 4,200,000 | $2.91M | SEC filing |
| CITIZENS FINANCIAL GROUP INC/RI | 2026-03-31 | 18,000 | $12.5K | SEC filing |
| Cetera Investment Advisers | 2026-03-31 | 69,875 | $48.4K | SEC filing |
| NISA INVESTMENT ADVISORS, LLC | 2026-03-31 | 2,252 | $1.56K | SEC filing |
| Federation des caisses Desjardins du Quebec | 2026-03-31 | 23,536 | $16.3K | SEC filing |
| FMR LLC | 2026-03-31 | 2,308 | $1.6K | SEC filing |
| OSAIC HOLDINGS, INC. | 2026-03-31 | 39,463 | $27.2K | SEC filing |
| Euclidean Capital LLC | 2026-03-31 | 1,015,705 | $703K | SEC filing |
| UBS Group AG | 2026-03-31 | 665,180 | $460K | SEC filing |
| Alphabet Inc. | 2026-03-31 | 915,705 | $632K | SEC filing |
| COMMERCE BANK | 2026-03-31 | 15,000 | $10.4K | SEC filing |
| Mirae Asset Global Investments Co., Ltd. | 2026-03-31 | 11,306 | $7.83K | SEC filing |
| Redhawk Wealth Advisors, Inc. | 2026-03-31 | 65,350 | $45.2K | SEC filing |
| Tower Research Capital LLC (TRC) | 2026-03-31 | 817 | $566 | SEC filing |
| WELLS FARGO & COMPANY/MN | 2026-03-31 | 2,000 | $1.38K | SEC filing |
| Marex Group plc | 2026-03-31 | 235,500 | $163K | SEC filing |
| Integrity Wealth Solutions LLC | 2026-03-31 | 39,708 | $27.5K | SEC filing |
| Steward Partners Investment Advisory, LLC | 2026-03-31 | 7,558 | $5.23K | SEC filing |
| Integrated Wealth Concepts LLC | 2026-03-31 | 23,940 | $16.6K | SEC filing |
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- XTX Topco Ltd: 105,692 shares reported 2025-12-31; 29,202 shares reported 2026-03-31.
- Mariner, LLC: 22,071 shares reported 2025-12-31; 22,000 shares reported 2026-03-31.
- Pathstone Holdings, LLC: 75,000 shares reported 2025-12-31; 75,000 shares reported 2026-03-31.
- MORGAN STANLEY: 208,431 shares reported 2025-12-31; 268,505 shares reported 2026-03-31.
- IFP Advisors, Inc: 16 shares reported 2025-12-31; 5,978 shares reported 2026-03-31.
- GEODE CAPITAL MANAGEMENT, LLC: 1,193,355 shares reported 2025-12-31; 1,559,939 shares reported 2026-03-31.
- Sequoia Financial Advisors, LLC: 10,725 shares reported 2025-12-31; 10,725 shares reported 2026-03-31.
- TWO SIGMA INVESTMENTS, LP: 1,266,075 shares reported 2025-12-31; 1,280,390 shares reported 2026-03-31.
- GOLDMAN SACHS GROUP INC: 67,977 shares reported 2025-12-31; 154,801 shares reported 2026-03-31.
- OMERS ADMINISTRATION Corp: 236,400 shares reported 2025-12-31; 207,100 shares reported 2026-03-31.
- Mirador Capital Partners LP: 582,524 shares reported 2025-12-31; 886,917 shares reported 2026-03-31.
- Optiver Holding B.V.: 54 shares reported 2025-12-31; 94 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
86 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Tenaya Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-02-25 · Svennilson Peter: Larger than 62 of the 65 other insider sales of Common Stock on file. SEC filing
- 2026-02-25 · Svennilson Peter: Larger than 63 of the 65 other insider sales of Common Stock on file. SEC filing
- 2026-02-24 · Svennilson Peter: Larger than 61 of the 65 other insider sales of Common Stock on file. SEC filing
- 2026-02-24 · Svennilson Peter: Larger than 60 of the 65 other insider sales of Common Stock on file. SEC filing
- 2026-02-20 · Svennilson Peter: Larger than 59 of the 65 other insider sales of Common Stock on file. SEC filing
- 2026-02-11 · Svennilson Peter: Larger than all 65 other insider sales of Common Stock on file. SEC filing
- 2026-02-11 · Svennilson Peter: Larger than 64 of the 65 other insider sales of Common Stock on file. SEC filing
- 2025-03-05 · GOEDDEL DAVID V: Larger than 18 of the 19 other insider purchases of Common Stock on file. SEC filing
- 2025-03-05 · COLUMN GROUP III-A, LP: Larger than 18 of the 19 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2025-03-05–2025-03-05: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2025-03-05–2025-03-05: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2025-03-05–2025-03-05: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2024-02-12–2024-02-12: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2023-03-10–2023-03-10: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2023-02-08–2023-02-08: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2023-01-17–2023-01-19: 6 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing )
- 2022-11-17–2022-11-21: 4 event(s) across 4 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing )
- 2021-08-03–2021-08-03: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-05-18 | Ali Faraz · Chief Executive Officer | Common Stock | S — Open market or private sale | −3,390 | 0.79 | SEC filing |
| 2026-05-18 | Higa Tomohiro · SVP, Finance | Common Stock | S — Open market or private sale | −1,485 | 0.79 | SEC filing |
| 2026-05-18 | Tingley Whittemore · Chief Medical Officer | Common Stock | S — Open market or private sale | −3,121 | 0.79 | SEC filing |
| 2026-02-25 | Svennilson Peter · 10% owner | Common Stock | S — Open market or private sale | −1,862,545 | 0.56 | SEC filing |
| 2026-02-25 | Svennilson Peter · 10% owner | Common Stock | S — Open market or private sale | −1,649,281 | 0.56 | SEC filing |
| 2026-02-24 | Svennilson Peter · 10% owner | Common Stock | S — Open market or private sale | −309,228 | 0.62 | SEC filing |
| 2026-02-24 | Svennilson Peter · 10% owner | Common Stock | S — Open market or private sale | −349,212 | 0.62 | SEC filing |
| 2026-02-23 | Svennilson Peter · 10% owner | Common Stock | S — Open market or private sale | −143,709 | 0.60 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-28 | Walsh Jeffrey T. · Director | Stock Option (Right to buy) | A — Grant, award, or other acquisition | +120,000 | SEC filing |
| 2026-05-28 | Burroughs Amy L. · Director | Stock Option (Right to buy) | A — Grant, award, or other acquisition | +120,000 | SEC filing |
| 2026-05-28 | Stehman-Breen Catherine · Director | Stock Option (Right to buy) | A — Grant, award, or other acquisition | +120,000 | SEC filing |
| 2026-05-28 | Srivastava Deepak · Director | Stock Option (Right to buy) | A — Grant, award, or other acquisition | +120,000 | SEC filing |
| 2026-05-28 | Lee June · Director | Stock Option (Right to buy) | A — Grant, award, or other acquisition | +120,000 | SEC filing |
| 2026-05-28 | Williams R Sanders · Director | Stock Option (Right to buy) | A — Grant, award, or other acquisition | +120,000 | SEC filing |
| 2026-05-28 | Parschauer Karah Herdman · Director | Stock Option (Right to buy) | A — Grant, award, or other acquisition | +120,000 | SEC filing |
| 2026-02-03 | Tingley Whittemore · Chief Medical Officer | Stock Option (Right to buy) | A — Grant, award, or other acquisition | +318,500 | SEC filing |
Showing 8 of 20 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2025-02-06 | Ali Faraz · Chief Executive Officer | Stock Option (Right to Buy) | D — Disposition to the issuer | −401,390 | SEC filing |
| 2025-02-06 | Ali Faraz · Chief Executive Officer | Stock Option (Right to Buy) | D — Disposition to the issuer | −353,271 | SEC filing |
| 2025-02-06 | Ali Faraz · Chief Executive Officer | Stock Option (Right to Buy) | D — Disposition to the issuer | −161,214 | SEC filing |
| 2025-01-24 | Tingley Whittemore · Chief Medical Officer | Stock Option (Right to Buy) | D — Disposition to the issuer | −69,982 | SEC filing |
| 2025-01-24 | Tingley Whittemore · Chief Medical Officer | Stock Option (Right to Buy) | D — Disposition to the issuer | −141,000 | SEC filing |
| 2025-01-24 | Tingley Whittemore · Chief Medical Officer | Stock Option (Right to Buy) | D — Disposition to the issuer | −215,000 | SEC filing |
| 2025-01-24 | Tingley Whittemore · Chief Medical Officer | Stock Option (Right to Buy) | D — Disposition to the issuer | −205,000 | SEC filing |
Showing 7 of 7 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.